If you can still get excited about diabetes research headlines, then here’s some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type 1 diabetes. If everything goes to plan, a representative of the company says, Tolerx could launch the first-ever offering approved by the FDA to treat the cause of type 1 diabetes. Pretty cool!…Read more »
Robert Oringer is currently Co-Chairman and Board Director of AMG Medical Inc. in Canada, which distributes professional and home healthcare products. But he’s also the man who pioneered private-label diabetes products in the US, including syringes, glucose products, and testing supplies.
One might call Robert a serial diabetes entrepreneur — and at least as importantly, father of two teenage boys with type 1 diabetes. We catch up with him today in his role as a…Read more »
I’m sure many of you heard the news yesterday that Roche Diabetes has acquired Israel-based Medingo, makers of the much-anticipated Solo insulin patch pump — a would-be direct competitor to the OmniPod tubeless pumping system.
Roche paid $160 million for the small company and its technology, which is a drop in the bucket in industry terms. The press release predicts “worldwide availability by 2012.”
In case you’re wondering, the Solo system already had an integrated…
Last week, my husband and I took the whole gang — three kids plus my oldest daughter’s best friend — on a roadtrip down to LA for Spring Break. Seven hours in the car is never a great experience, but now that their ages range from 7-12, it’s getting much less painless. (No one barfed! Not even me)
For our “roller coaster day” at Knott’s Berry Farm, my 12-year-old and her BFF wore a set of…
Not long ago, I reported here on the possible benefits of Metformin for people with type 1 diabetes. It is of course an oral medication traditionally aimed at type 2 diabetics who are not on insulin. Today, we revisit that issue with a real live test case — my friend and colleague Allison Blass, who’s recently added Metformin to her own regime:
A Guest Post by Allison Blass
Over the past few years, since graduating…